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On the osteogenic expression
induced by calcium/phosphate
deposition
To the Editor: In a recently published paper in this journal,
Professor Demer’s group1 suggests that calcium/phosphate
crystals (hydroxyapatite) induce the expression of osteogenic
genes, Bmp2 and Osteopontin, in vascular smooth muscle
cells. This conclusion agrees with another recent paper from
our group.2
Calcium/phosphate-induced calciﬁcation is a process of
hydroxyapatite deposition that is initially independent of any
cell activity or metabolism.2 The initial step consists of passive
calcium/phosphate deposition, in which the role of calcium
is more prominent than that of phosphate,2,3 according to
recent studies by both Professor Shanahan’s group3 and our
group.2 The reason for this is that a high concentration of
phosphate (4mmol/l) in the presence of a low concentration
of calcium (1mmol/l) does not produce calcium/phosphate
deposition or upregulation in the expression of osteogenic
genes.2 By contrast, high concentrations of calcium (4mmol/l)
in the presence of 1mmol/l phosphate induces both the
formation of calcium/phosphate crystals and upregulation in
the expression of osteogenic genes Cbfa1 and Bmp2 (Figure 1).2
Although it was previously accepted that the expression of
osteogenes induced the formation of hydroxyapatite deposits,
all these studies now show that calcium/phosphate deposition
is indeed responsible for osteogene expression under
hyperphosphatemic conditions. Moreover, a cell attempts to
prevent these deposits by producing inhibitors.2 These results
are taking another look at the role of phosphate and related Pi
transport inside the cell during the calciﬁcation process.4
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The Authors Reply: We appreciate the comments from
Sorribas and Villa-Bellosta1 and are pleased to see that Professor
Sorribas and colleagues2 have simultaneously and indepen-
dently made observations similar to ours:3 that, under
hyperphosphatemic conditions in vitro, calcium phosphate
nanocrystal formation can be initiated independently of cells.
Both sets of ﬁndings introduce a novel, alternative mechanism
for osteogenic gene induction and further support the concept
that the stages of vascular calciﬁcation, much like those of bone
mineralization, are actively regulated. Thus, depending on the
underlying clinical or culture conditions, mineralization may be
governed by a wide variety of nucleators, inhibitors, and
activators as detailed by George and Veis.4
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Figure 1 |Comparison of total calcium deposition, and Bmp-2
and Cbfa1 expressions in vascular smooth muscle cells after 3
days of incubation with the indicated concentrations of
calcium and phosphate in MEM culture medium. *Statistically
different from the 2 mmol/l Ca2þ , 1mmol/l Pi condition.
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